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Abstract 
Purpose: To investigate the reno-protective properties of Cinnamomum tamala against gentamicin-
induced nephrotoxicity in rabbits.  
Methods: Rabbits were randomly divided into four groups (n = 6) including Group-1 (normal saline), 
Group-2 (gentamicin, 80 mg/kg/day), Group-3 (C. tamala, 200 mg/kg/day) and Group-4 (gentamicin, 80 
mg/kg/day and C. tamala, 200 mg/kg/day). Body weight, blood urea nitrogen, serum creatinine, 
creatinine clearance, serum uric acid, urinary volume and urinary protein excretion were measured 
followed by histological examination.  
Results: Gentamicin-treated animals showed significant renal damage as indicated by rise in blood 
urea nitrogen (54.18 ± 2.60 mg/dl), serum creatinine (4.02 ± 0.14 mg/dl), serum uric acid (2.34 ± 0.12 
mg/dl), urinary proteins (3.86 ± 0.32 mg/dl) and decrease in creatinine clearance (0.76 ± 0.09ml/min), 
urinary volume (126.00 ± 9.09 ml) and body weight (10.80 ± 1.09 %). However, animals treated with 
gentamicin and C. tamala significantly protected rabbit kidney from structural and functional changes 
associated with gentamicin.  
Conclusion: Based on the findings, it is apparent that concurrent administration of 200 mg/kg/day of C. 
tamala leaf extract and gentamicin effectively prevented gentamicin-induced renal damage. 
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Cinnamomum tamala (Lauraceae) is commonly 
known as tejpat and tejpatra in Sanskrit [1]. The 
plant is widely found in Asia and Australia [2] and 
its major constituents are a-pinene, myrcene, 
camphene, p-cymene, limonene, eugenol and 
methyl eugenol [3]. The plant has different 
medicinal properties like carminative, diuretic, 
anti-flatulent effects and is also useful in heart 
abnormalities [2]. The usefulness of C. tamala in 
the treatment of anorexia, nausea, mouth 
dryness, diarrhea and bladder disorder has also 
been described [4]. The plant possesses 
hypolipidemic and hypoglycemic properties [5] 
and has potent antibacterial activity against 
Escherichia coli, Bacillus subtilis and 
Saccharomyces cerevisiae [6]. C. tamala has 
been used in folk medicine as brain tonic and 
anthelmintic especially for the treatment of anal 
and rectal diseases [1]. It is reported that C. 
tamala leaves have gastro-protective effects in 
experimental animals, may be because of free 
radical scavenging properties [7]. The plant has 
also been reported with high phenolic contents 
and has concentration-dependent antioxidant 
activities [8]. In view of this, the plant extract may 
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inhibit oxidative damage and protect against 
gentamicin-induced renal toxicity. The objective 
of the present study, therefore, was to investigate 





Plant material and extraction 
 
C. tamala leaves were collected from Northern 
areas of Pakistan in the year 2010. Following 
authentification by Professor Umar Farooq, 
Department of Botany, Postgraduate College 
No.1, Abbottabad, Pakistan, a voucher specimen 
was deposited in the herbarium of the same 
department.  
 
The fresh leaves were washed, shade-dried and 
ground with a grinder (ZK-115, Japan). 
Extraction was done with sufficient quantity of 70 
% ethanol with intermittent stirring for three 
weeks. The mixture was filtered and the 
supernatant evaporated using a rotary 
evaporator (R-210 Germany) [9].  
 
Experimental protocol  
 
Four groups of animal, each having six male 
rabbits of similar weights, were acclimatized for 
15 days before the start of study in the animal 
house of Frontier Medical and Dental College, 
Abbottabad, Pakistan. All the rabbits were 
maintained on the same diet and 12 h light/dark 
cycle. Animal handling and care was strictly 
according to the rules and regulations of 
University of Malakand, along with international 
laws and policies (National Institutes of Health 
Guide for the Care and Use of oratory Animals, 
NIH Publication no. 85-23, 1985) after 
institutional approval of the study by Research 
Society of the university. The extract was given 
orally while gentamicin (Merck, Pakistan) was 
injected intramuscularly to induce nephrotoxicity 
according to the treatment schedule in Table 1.  
 








1 C (control) 0.9% saline (2 ml/kg, im) 
2 G (toxic) Gentamicin (80 mg/kg, im) 
3 GC-ta Gentamicin (80 mg/kg/, im) 
+ C. tamala (200 mg/kg, 
po). 
4 C-ta C. tamala (200 mg/kg, po). 
 
Blood samples were collected three times 
throughout the experimental period for the 
estimation of serum creatinine, creatinine 
clearance, blood urea nitrogen and serum uric 
acid. Urine was also collected from the mesh 
beneath the cages on days 0, 11 and 21 for the 
assessment of urinary creatinine, urinary protein 
and urinary volume. The body weight of each 
rabbit was measured with digital balance (Excel, 
China) three times throughout the study period. 
Determination of blood urea nitrogen (BUN) was 
performed by Bertholot’s indophenol procedure, 
using a reagent kit (ProDia International, UAE), 
while determination of serum creatinine and 
urinary creatinine was performed by the Jaffe 
reaction [10]. Chemistry analyzer (Power Lab 
300, Merck, Germany) was used for the 
evaluation of serum uric acid using a 
commercially available kit (ProDia International, 




On the last day of experiment, half of the rabbits 
in each group were sacrificed. The kidneys were 
isolated and cut longitudinally and transversely; 
and fixed in 10 % formal-saline solution. The 
tissues were dehydrated with ethanol in the 
following alcohol concentration sequence: 50, 70 
and 90 %. Finally, the absolute alcohol was 
applied, after using xylene solution for clearing 
purpose. The tissues were then fixed with help of 
paraffin wax. Rotatory microtome (Micros, 
Germany) was used for the sectioning of 
solidified blocks. The slides were stained with 
hematoxylin and eosin dyes and examined with a 




One-way ANOVA was used for comparison of 
groups following Dunnett test using Graph Pad 
Prism (version-5) software. The results were 
expressed as Mean ± SEM. Statistical 





Changes in body weight 
 
Gentamicin treated animals lost 10.795 ± 1.09% 
of body weight significantly different from control 
group animals 0.155  0.91%, P < 0.0001. 
Further, animals treated with C. tamala lost 0.95 
± 0.67% of body weight while animals treated 
with simultaneous administration of C. tamala 
and gentamicin lost Lab 1.26 ± 0.30% of body 
weight significantly different from gentamicin 
treated animals (P < 0.0001) as given in Table 2.  
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Table 2: Mean body weight (mean ± SEM, n = 6) of 














C 1.312 1.308 1.310 0.16 ± 
0.91*** 
G 1.210 1.166 1.080 10.80 ± 
1.09 
GC-ta 1.302 1.295 1.286 1.26 ± 
0.30** 
C-ta 1.258 1.252 1.246 0.95 ± 
0.67*** 
 ** p < 0.05, *** p < 0.001 denote significantly different 
compared with control 
 
Blood urea nitrogen (BUN) 
 
Blood orea nitrogen was elevated in gentamicin-
treated animals on day 11 (37.78  2.14 mg/dl 
compared with control 13.75  1.04 mg/dl (p < 
0.0001) and on day 21 (54.18  2.6 mg/dl 
compared with control 14.14  1.12 mg/dl, p < 
0.0001). Further, group GC-ta and C-ta was 
significantly different compared with gentamici-




Serum creatinine increased significantly in 
gentamicin treated animals on day 11 (1.96 ± 
0.14 mg/dl compared with control 0.71 ± 0.10 
mg/dl, p < 0.0001) and further increased on day 
21 (4.02 ± 0.14 mg/dl compared with control 0.80 
± 0.10 mg/dl, p < 0.0001). Group GC-ta and C-ta 
was significantly different compared with 
gentamicin treated animals (p < 0.0001) as given 




Creatinine clearance decreased significantly in 
gentamicin treated animals on day 11 (2.08 ± 
0.25 ml/min compared with control 5.08 ± 0.82 
ml/min, p = 0.0058) and further decreased on 
day 21 (0.76±0.09 ml/min compared with control 
4.99±1.16 ml/min, p = 0.0047). Group GC-ta and 
C-ta was significantly different compared with 
gentamicin treated animals on day 21 (p < 
0.0001) as given in Table 3.  
 
Serum uric acid 
 
Serum uric acid was significantly elevated in 
gentamicin treated animals on day 21 (2.34 ± 
0.12 mg/dl compared with control 1.51 ± 0.02 
mg/dl, p = 0.0058). Further, serum uric acid of 
group GC-ta and C-ta was significantly different 
compared with gentamicin treated animals (p = 
0.0013 and < 0.0001, respectively) as given in 
Table 3.  
 
Table 3: Serum BUN, creatinine, creatinine clearance 












































** p < 0.05, *** p < 0.001 denote significantly different 




Urinary protein increased significantly in 
gentamicin treated animals on day 11 (2.51 ± 
0.30 mg/dl compared with control 1.64 ± 0.17 
mg/dl, p = 0.0329), and further increased on day 
21 (3.86 ± 0.32 mg/dl compared with control 1.81 
± 0.22 mg/dl, p = 0.0004). Further, Group GC-ta 
and C-ta was significantly different from 
gentamicin treated animals on day 21 of study 
period (p = 0.0002 and 0.0013 respectively) as 







































Urinary volume of gentamicin treated animals 
was statistically unchanged on day 11 (168 ± 
11.96 ml compared with control 200 ± 9.16 ml, P 
= 0.0596).  However on day 21 it was 
significantly decreased (126 ± 9.09 ml compared 
with control 217 ± 19.77 ml, P = 0.0019). Further, 
urinary volume of group GC-ta and C-ta was 
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significantly different from gentamicin treated 
animals on day 21 (P = 0.0003 and 0.0002 


































Fig 2: Twenty four- (24-) hour urine volumes of groups 




Most of toxic group animals showed ruptured 
tubular cells with hydropic changes as shown in 
Fig 3C. Cellular pattern was lost with the 
presence of necrosis, mostly detected in the 
proximal tubules (Fig 3C). Atropy of glomeruli 
with increased cellularity was also found in 
gentamicin treated animals. Few ruptured 
tubules were also seen in the medulla of group 
GC-ta and gentamicin treated animals (Fig 3D, 
F). The number of ruptured and necrotic cells 
diagnosed in other groups was not significant 
when compared with the toxic group (Fig 3A, B, 
E, G, H). 
 
      
 
Fig 3: Photomicrographs of kidney sections (H & E ˟ 
200): (A) renal cortex of control group presenting 
normal glomerular structures. (B) renal medulla of 
control group presenting normal tubules. (C) renal 
cortex of gentamicin treated group showing glomerular 
and proximal tubular necrosis. (D) renal medulla of 
gentamicin treated group presenting ruptured tubules 
and hydropic changes. (E) renal cortex of group GC-ta 
presenting normal glomeruli. (F) renal medulla of 
group GC-ta showing some ruptured tubules (G) renal 
cortex of group C-ta presenting normal structures (H) 
renal medulla showing normal tubules. 
DISCUSSION 
 
The present study was aimed to investigate the 
nephroprotective potentials of C. tamala against 
gentamicin-induced toxicity. Renal damage 
caused by gentamicin depends upon the dose 
and duration of the treatment. Different 
researchers used different doses, ranging 
between 8 and 80mg/kg/day to produce renal 
damage [11]. However, these toxic effects are 
only associated if the drug is taken five to ten 
times normal doses [12, 13]. Therefore, in the 
current study we used a daily dose of 80 mg/kg 
of gentamicin for a period of 21 days to produce 
significant nephrotoxic effects.  
 
Rise in serum creatinine and necrosis of tubules 
have been reported in animals given daily doses 
of 30 – 60 mg/kg gentamicin for 5 – 10 days [12-
14]. Elevation in BUN and serum creatinine and 
significant fall in creatinine clearance has been 
reported with the toxic use of gentamicin [14] 
which was in agreement with the current findings 
for gentamicin treated animals. The protective 
role of C. tamala extract can easily be concluded 
from current results.  
 
Gentamicin treated animals significantly lost their 
body weight compared with control group. 
However, extract-treated animals did not show 
significant loss in their body weight when 
compared with gentamicin treated animals. The 
blocking of tubules by necrotic debris and leaking 
of filtrate through the ruptured tubules might be 
responsible for the rise in serum creatinine [15]. 
However, it has also been reported that tubular 
necrosis and alteration in renal function 
parameters are independent of each other 
[14,16].  
 
A significant fall in urinary volume and rise in 
urinary protein was observed in gentamicin-
treated animals which were significantly different 
from those of control and extract-treated groups; 
this is suggestive of the protection afforded by C. 
tamala. In the current study, histopathological 
examination of kidney revealed the presence of 
regenerating cells, necrosis and hydropic 
changes in gentamicin-treated animals as 
reported previously [13,17,18]. Elevation of 
protein excretion may due to cellular 
degeneration caused by the accumulation of 
hyaline and granular casts in the proximal 
tubules. The blockade of tubules by cast cells 
may be a reasonable cause for the induction of 
nephrotoxicity associated with gentamicin 
[15,18]. The fact that there were no significant 
necrosis, derangement of cells, hydropic 
changes and hyaline were detected in control 
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and extract-treated animals confirms the 




Increase in serum creatinine, blood urea nitrogen 
and serum uric acid, and fall in creatinine 
clearance with morphological changes, usually 
induced by gentamycin, can be prevented by co-
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